A physicogenetic method to assign ligand-binding relationships between 7TM receptors

Area of Science:

• Computational chemistry and structural biology
• Pharmacology and drug discovery

Background:

• Seven-transmembrane receptors (GPCRs) are crucial drug targets.
• Understanding ligand-binding sites is key for rational drug design.
• Existing methods lack a systematic approach to link GPCR structure to ligand properties.

Purpose of the Study:

• To develop a computational protocol for relating GPCRs based on ligand-binding site physicochemical features.
• To support structure-guided drug design of novel ligands for GPCRs.
• To demonstrate the protocol's utility using the prostaglandin D2 receptor CRTH2 as a case study.

Main Methods:

• Devised a computational protocol to analyze physicochemical features of GPCR ligand-binding sites.
• Utilized crystal structure data, specifically from bovine rhodopsin, as a reference.
• Integrated existing ligand information, including mutagenesis and structure-activity relationship (SAR) data.

Main Results:

• Established a method to computationally relate GPCRs based on their binding site characteristics.
• Successfully applied the protocol to the prostaglandin D2 receptor CRTH2, a newly identified target.
• Demonstrated the potential for identifying GPCRs amenable to structure-guided ligand design.

Conclusions:

• The developed computational protocol provides a framework for understanding GPCR-ligand interactions.
• This approach facilitates the identification of suitable GPCR targets for drug discovery.
• Structure-guided drug design for GPCRs can be significantly advanced by this methodology.